Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

Kasami M, Vnencak-Jones CL, Manning S, Dupont WD, Page DL
Am J Pathol. 1997 150 (6): 1925-32

PMID: 9176386 · PMCID: PMC1858322

Loss of heterozygosity and microsatellite instability have been often reported in breast cancer and seldom in proliferative breast disease (PBD). DNA samples from microdissected PBD lesions, including papillomas (25 lesions), from 8 women were analyzed by polymerase chain reaction for loss of heterozygosity and microsatellite instability at 10 loci including INT-2 oncogene locus, D17S796 (the p53 gene region), and D17S579 (in the region of the BRCA-1 gene). In a patient, five loci with microsatellite instability and two loci with loss of heterozygosity were identified in one papilloma with florid hyperplasia and atypia, and 10 other PBD lesions were negative for genetic alteration (GA) and atypia. Three loci with microsatellite instability were identified in another PBD lesion without atypia, whereas another lesion from this second patient had minimal atypia without GAs. These two patients have been well for more than 20 years. No other patient, including a woman developing cancer, had GAs. We detected GAs in PBD (25% of women, 8% of lesions). Incomplete correlation between GAs and anatomic atypia was suggested. It seems evident that several GAs in PBD lesions may not indicate clinically meaningful premalignancy for remaining breast.

MeSH Terms (18)

Adolescent Adult Aged Aged, 80 and over Biopsy Breast Diseases Breast Neoplasms Chromosome Deletion DNA Female Genetic Markers Heterozygote Humans Hyperplasia Microsatellite Repeats Middle Aged Polymerase Chain Reaction Prognosis

Connections (1)

This publication is referenced by other Labnodes entities: